Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1).
about
Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trialA prospective randomised controlled clinical trial comparing a combination of repeated intravitreal Ozurdex and macular laser therapy versus macular laser only in centre-involving diabetic macular oedema (OZLASE study).Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study.Interocular anatomical and visual functional differences in pediatric patients with unilateral cataractsA randomized clinical trial comparing fixed vs pro-re-nata dosing of Ozurdex in refractory diabetic macular oedema (OZDRY study).Health-related quality of life, visual function and treatment satisfaction following intravitreal dexamethasone implant for diabetic macular edema.Real-life clinical data for dexamethasone and ranibizumab in the treatment of branch or central retinal vein occlusion over a period of six months.Monthly microperimetry (MP1) measurement of macular sensitivity after dexamethasone implantation (Ozurdex) in retinal vein occlusions.Acuity and colour vision changes post intravitreal dexamethasone implant injection in patients with diabetic macular oedema.Analysis of Morphologic and Functional Outcomes in Macular Edema due to Central Retinal Vein Occlusion Treated with Intravitreal Dexamethasone Implant
P2860
Q31117687-03B69F5D-AC20-4540-8097-FDA418DEC751Q35809696-EEB4F8EF-90E5-4814-BA65-CD78AA7286AEQ35828114-02428E1C-9CC5-444B-99BA-ADA3D4471EA1Q36181546-07ACEFB0-C52C-4AEF-B6C5-B5571104EE88Q37457147-018A2D8D-7B16-4DB5-A0FE-DABF64E71D3CQ37718835-77D7585B-56E5-486B-A439-D53D76EC6822Q47399241-FD5C0308-C415-4DD6-9C8D-A2DAF742B3E3Q52870646-ACCB0EF0-6C6E-46E4-A9DD-CC324D41A12DQ55447099-A4526BED-99A9-49E7-B01F-D1176D9A9FC6Q57115851-648CCA17-C817-4A9F-AD79-2CE0D9807BBA
P2860
Monthly OCT monitoring of Ozurdex for macular oedema related to retinal vascular diseases: re-treatment strategy (OCTOME Report 1).
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Monthly OCT monitoring of Ozur ...... nt strategy (OCTOME Report 1).
@ast
Monthly OCT monitoring of Ozur ...... nt strategy (OCTOME Report 1).
@en
type
label
Monthly OCT monitoring of Ozur ...... nt strategy (OCTOME Report 1).
@ast
Monthly OCT monitoring of Ozur ...... nt strategy (OCTOME Report 1).
@en
prefLabel
Monthly OCT monitoring of Ozur ...... nt strategy (OCTOME Report 1).
@ast
Monthly OCT monitoring of Ozur ...... nt strategy (OCTOME Report 1).
@en
P2093
P2860
P356
P1433
P1476
Monthly OCT monitoring of Ozur ...... nt strategy (OCTOME Report 1).
@en
P2093
P2860
P2888
P304
P356
10.1038/EYE.2013.287
P577
2014-01-03T00:00:00Z